A Mutually Inhibitory Feedback Loop between the 20S Proteasome and Its Regulator, NQO1

Molecular Cell

Volumn 47, Issue 1, 2012, Pages 76-86

  Moscovitz, Oren ^a   Tsvetkov, Peter ^a   Hazan, Nimrod ^a   Michaelevski, Izhak ^b   Keisar, Hodaya ^a   Ben Nissan, Gili ^a   Shaul, Yosef ^a   Sharon, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; NADPH QUINONE OXIDOREDUCTASE 1; PROTEASOME; PROTEASOME 20S; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL METABOLISM; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT;

ANIMALS; APOENZYMES; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME STABILITY; FEEDBACK, PHYSIOLOGICAL; FLAVIN-ADENINE DINUCLEOTIDE; HEK293 CELLS; HELA CELLS; HUMANS; MASS SPECTROMETRY; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NAD(P)H DEHYDROGENASE (QUINONE); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN FOLDING; PROTEOLYSIS; RATS; RECOMBINANT PROTEINS; TEMPERATURE;

EID: 84863816082     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.05.049     Document Type: Article

References (44)

1. Adler J., Reuven N., Kahana C., Shaul Y. c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol. Cell. Biol. 2010, 30:3767-3778.
2. Alard A., Fabre B., Anesia R., Marboeuf C., Pierre P., Susini C., Bousquet C., Pyronnet S. NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome. Mol. Cell. Biol. 2010, 30:1097-1105.
3. Anwar A., Dehn D., Siegel D., Kepa J.K., Tang L.J., Pietenpol J.A., Ross D. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J. Biol. Chem. 2003, 278:10368-10373.
4. Asher G., Tsvetkov P., Kahana C., Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 2005, 19:316-321.
5. Asher G., Dym O., Tsvetkov P., Adler J., Shaul Y. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 2006, 45:6372-6378.
6. Baugh J.M., Viktorova E.G., Pilipenko E.V. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J. Mol. Biol. 2009, 386:814-827.
7. Benson A.M., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 1980, 77:5216-5220.
8. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003, 115:71-82.
9. Chen S., Wu K., Knox R. Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2). Free Radic. Biol. Med. 2000, 29:276-284.
10. Chernushevich I.V., Thomson B.A. Collisional cooling of large ions in electrospray mass spectrometry. Anal. Chem. 2004, 76:1754-1760.
11. De Long M.J., Prochaska H.J., Talalay P. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc. Natl. Acad. Sci. USA 1986, 83:787-791.
12. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
13. Dinkova-Kostova A.T., Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 2010, 501:116-123.
14. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6:197-208.
15. Ernster L., Navazioi F. Soluble diaphorase in animal tissues. Acta Chem. Scand. 1958, 12:595.
16. Freiburger L.A., Baettig O.M., Sprules T., Berghuis A.M., Auclair K., Mittermaier A.K. Competing allosteric mechanisms modulate substrate binding in a dimeric enzyme. Nat. Struct. Mol. Biol. 2011, 18:288-294.
17. Garate M., Wong R.P., Campos E.I., Wang Y., Li G. NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep. 2008, 9:576-581.
18. Glickman M.H., Rubin D.M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V.A., Finley D. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 1998, 94:615-623.
19. Goldberg A.L., Dice J.F. Intracellular protein degradation in mammalian and bacterial cells. Annu. Rev. Biochem. 1974, 43:835-869.
20. Gsponer J., Futschik M.E., Teichmann S.A., Babu M.M. Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 2008, 322:1365-1368.
21. Hautreux M., Hue N., de Kerdaniel A.D., Zahir A., Malec V., Laprévote O. Under non-denaturing solvent conditions, the mean charge state of a multiply charged protein ion formed by electrospray is linearly correlated with the macromolecular surface. Int. J. Mass Spectrom. 2004, 231:131-137.
22. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
23. Hershkovitz Rokah O., Shpilberg O., Granot G. NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest. PLoS ONE 2010, 5:e11401.
24. Huberts D.H., van der Klei I.J. Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta 2010, 1803:520-525.
25. Hustad S., Ueland P.M., Schneede J. Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laser-induced fluorescence detection. Clin. Chem. 1999, 45:862-868.
26. Jariel-Encontre I., Bossis G., Piechaczyk M. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 2008, 1786:153-177.
27. Jeffery C.J. Moonlighting proteins-an update. Mol Biosyst 2009, 5:345-350.
28. Kaltashov I.A., Mohimen A. Estimates of protein surface areas in solution by electrospray ionization mass spectrometry. Anal. Chem. 2005, 77:5370-5379.
29. Lee S.S., McCormick D.B. Thyroid hormone regulation of flavocoenzyme biosynthesis. Arch. Biochem. Biophys. 1985, 237:197-201.
30. Li R., Bianchet M.A., Talalay P., Amzel L.M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc. Natl. Acad. Sci. USA 1995, 92:8846-8850.
31. Manthey K.C., Rodriguez-Melendez R., Hoi J.T., Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J. Nutr. Biochem. 2006, 17:250-256.
32. Mason E.A., McDaniel E.W. Transport properties of ions in gases 1988, John Wiley & Sons, New York.
33. Michaelevski I., Kirshenbaum N., Sharon M. T-wave ion mobility-mass spectrometry: basic experimental procedures for protein complex analysis. J. Vis. Exp. 2010, (41).
34. Nagao M., Tanaka K. FAD-dependent regulation of transcription, translation, post-translational processing, and post-processing stability of various mitochondrial acyl-CoA dehydrogenases and of electron transfer flavoprotein and the site of holoenzyme formation. J. Biol. Chem. 1992, 267:17925-17932.
35. Ross D., Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 2004, 382:115-144.
36. Saijo T., Tanaka K. Isoalloxazine ring of FAD is required for the formation of the core in the Hsp60-assisted folding of medium chain acyl-CoA dehydrogenase subunit into the assembly competent conformation in mitochondria. J. Biol. Chem. 1995, 270:1899-1907.
37. Sharon M., Witt S., Felderer K., Rockel B., Baumeister W., Robinson C.V. 20S proteasomes have the potential to keep substrates in store for continual degradation. J. Biol. Chem. 2006, 281:9569-9575.
38. Siegel D., Anwar A., Winski S.L., Kepa J.K., Zolman K.L., Ross D. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol. Pharmacol. 2001, 59:263-268.
39. Sollner S., Schober M., Wagner A., Prem A., Lorkova L., Palfey B.A., Groll M., Macheroux P. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep. 2009, 10:65-70.
40. Tsvetkov P., Reuven N., Prives C., Shaul Y. Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. J. Biol. Chem. 2009, 284:26234-26242.
41. Tsvetkov P., Adamovich Y., Elliott E., Shaul Y. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J. Biol. Chem. 2011, 286:8839-8845.
42. Tu B.P., Weissman J.S. The FAD- and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell 2002, 10:983-994.
43. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
44. Yonezawa A., Masuda S., Katsura T., Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am. J. Physiol. Cell Physiol. 2008, 295:C632-C641.